K

Kura Oncology
D

KURA

8.26500
USD
0.12
(1.41%)
مغلق
حجم التداول
22,247
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
642,717,394
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    COLM
    0.461
    (0.51%)
    90.741 USD
    LULU
    LULU
    -6.76
    (-1.85%)
    358.91 USD
    NKE
    NKE
    -0.750
    (-0.97%)
    76.500 USD
    P
    PVH
    0.040
    (0.05%)
    78.710 USD
    R
    RL
    -8.88
    (-3.10%)
    277.69 USD
    U
    UAA
    -0.06000
    (-0.84%)
    7.09500 USD
    U
    ULTA
    -5.19
    (-1.42%)
    361.54 USD
    V
    VFC
    -0.970
    (-3.66%)
    25.505 USD
    المزيد
الأخبار
المقالات

العنوان: Kura Oncology

القطاع: Healthcare
الصناعة: Biotechnology
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operationof the group is carried through the United States.